Explain this page
Arphra AIPlain-English read on Incyte Corporation’s valuationInsider signal · 90d
Net sellers
Bought
$0
Sold
$3.6M
Txns
2
Over the trailing 90 days insiders are net sellers — $0 bought against $3.6M sold across 2 open-market Form-4 transactions. Much insider selling is scheduled (10b5-1); read the asymmetry, not any single print.
Open-market Form 4
· insider_tradesInsider transactions · last 365d
Net −$41.7M0 buys
| Insider | Role | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | −18,667 | $1.8M | Apr 17, 2026 |
| CAGNONI PABLO J | officer: President, R&D | Sell | −18,667 | $1.8M | Mar 17, 2026 |
| CAGNONI PABLO J | officer: President, R&D | Sell | −18,668 | $1.9M | Feb 19, 2026 |
| Issa Mohamed Khairie | officer: EVP, Head of US Oncology | Sell | −10,856 | $1.2M | Jan 07, 2026 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | −15,634 | $1.6M | Jan 05, 2026 |
| Tray Thomas | officer: Principal Accounting Officer | Sell | −2,774 | $277.4K | Dec 19, 2025 |
| Tray Thomas | officer: Principal Accounting Officer | Sell | −600 | $59.0K | Dec 18, 2025 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | Sell | −4,323 | $420.5K | Dec 17, 2025 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | Sell | −53,175 | $5.2M | Dec 16, 2025 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | Sell | −833 | $81.2K | Dec 16, 2025 |
| Mayes Patrick A | officer: EVP & Chief Scientific Officer | Sell | −255 | $24.2K | Dec 11, 2025 |
| Mayes Patrick A | officer: EVP & Chief Scientific Officer | Sell | −5,553 | $530.8K | Dec 10, 2025 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | −20,105 | $2.1M | Dec 02, 2025 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | −2,559 | $263.5K | Dec 01, 2025 |
Transaction mix · 365d
100%
Sells40 · $41.7M
Buys0 · $0
Top sellers · 365d
Hoppenot Herve · director−$19.8M
Stein Steven H · officer: EVP & Chief Medical Officer−$5.7M
Morrissey Michael James · officer: EVP, Head of Tech. Operations−$5.7M
Transactions
40
0 buys · 40 sells
Bought
$0
Open market
Sold
$41.65M
Open market
Net flow
−$41.65M
Buys − sells
Transactions
| Insider | Role | Action | Shares | Price | Value | Trade date | Filing |
|---|---|---|---|---|---|---|---|
| CAGNONI PABLO J | officer: President, Global Head of R&D | Sell | 18,667 | $96.50 | $1.8M | Apr 17, 2026 | Apr 21, 2026 |
| CAGNONI PABLO J | officer: President, R&D | Sell | 18,667 | $94.24 | $1.76M | Mar 17, 2026 | Mar 19, 2026 |
| CAGNONI PABLO J | officer: President, R&D | Sell | 18,668 | $100.91 | $1.88M | Feb 19, 2026 | Feb 23, 2026 |
| Issa Mohamed Khairie | officer: EVP, Head of US Oncology | Sell | 10,856 | $109.07 | $1.18M | Jan 07, 2026 | Jan 08, 2026 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | 15,634 | $101.70 | $1.59M | Jan 05, 2026 | Jan 07, 2026 |
| Tray Thomas | officer: Principal Accounting Officer | Sell | 2,774 | $100.00 | $277.4K | Dec 19, 2025 | Dec 22, 2025 |
| Tray Thomas | officer: Principal Accounting Officer | Sell | 600 | $98.25 | $58.95K | Dec 18, 2025 | Dec 22, 2025 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | Sell | 4,323 | $97.26 | $420.45K | Dec 17, 2025 | Dec 18, 2025 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | Sell | 53,175 | $97.29 | $5.17M | Dec 16, 2025 | Dec 18, 2025 |
| Morrissey Michael James | officer: EVP, Head of Tech. Operations | Sell | 833 | $97.42 | $81.15K | Dec 16, 2025 | Dec 18, 2025 |
| Mayes Patrick A | officer: EVP & Chief Scientific Officer | Sell | 255 | $94.94 | $24.21K | Dec 11, 2025 | Dec 12, 2025 |
| Mayes Patrick A | officer: EVP & Chief Scientific Officer | Sell | 5,553 | $95.58 | $530.76K | Dec 10, 2025 | Dec 12, 2025 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | 20,105 | $102.51 | $2.06M | Dec 02, 2025 | Dec 03, 2025 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | 2,559 | $102.96 | $263.47K | Dec 01, 2025 | Dec 03, 2025 |
| Tray Thomas | officer: Principal Accounting Officer | Sell | 600 | $103.00 | $61.8K | Nov 24, 2025 | Nov 25, 2025 |
| Tray Thomas | officer: Principal Accounting Officer | Sell | 169 | $102.00 | $17.24K | Nov 21, 2025 | Nov 25, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 278 | $104.36 | $29.01K | Nov 17, 2025 | Nov 19, 2025 |
| Hoppenot Herve | director | Sell | 187,500 | $105.46 | $19.77M | Nov 10, 2025 | Nov 12, 2025 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | 5,233 | $102.20 | $534.81K | Nov 05, 2025 | Nov 07, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 598 | $101.36 | $60.61K | Nov 04, 2025 | Nov 06, 2025 |
| Heeson Lee | officer: EVP, Head of Incyte Intl | Sell | 3,074 | $94.02 | $289.02K | Nov 03, 2025 | Nov 05, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 277 | $85.13 | $23.58K | Oct 15, 2025 | Oct 17, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 3,501 | $85.54 | $299.48K | Oct 03, 2025 | Oct 06, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 599 | $87.65 | $52.5K | Oct 02, 2025 | Oct 06, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 278 | $83.15 | $23.12K | Sep 16, 2025 | Sep 18, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 598 | $84.97 | $50.81K | Sep 02, 2025 | Sep 04, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 277 | $86.81 | $24.05K | Aug 15, 2025 | Aug 19, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 598 | $75.77 | $45.31K | Aug 04, 2025 | Aug 06, 2025 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | 3,706 | $67.94 | $251.79K | Jul 21, 2025 | Jul 23, 2025 |
| Flannelly Barry P | officer: EVP & General Manager US | Sell | 1,340 | $68.36 | $91.6K | Jul 16, 2025 | Jul 17, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 785 | $68.36 | $53.66K | Jul 16, 2025 | Jul 17, 2025 |
| Iyengar Vijay K | officer: EVP, GMAPPS | Sell | 983 | $68.36 | $67.2K | Jul 16, 2025 | Jul 17, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 3,330 | $69.86 | $232.63K | Jul 15, 2025 | Jul 17, 2025 |
| Iyengar Vijay K | officer: EVP, GMAPPS | Sell | 1,177 | $69.86 | $82.23K | Jul 15, 2025 | Jul 16, 2025 |
| Flannelly Barry P | officer: EVP & General Manager US | Sell | 1,192 | $69.86 | $83.27K | Jul 15, 2025 | Jul 16, 2025 |
| Stein Steven H | officer: EVP & Chief Medical Officer | Sell | 14,952 | $68.47 | $1.02M | Jul 14, 2025 | Jul 16, 2025 |
| Flannelly Barry P | officer: EVP & General Manager US | Sell | 10,903 | $68.15 | $743.04K | Jul 03, 2025 | Jul 07, 2025 |
| Iyengar Vijay K | officer: EVP, GMAPPS | Sell | 2,682 | $68.16 | $182.81K | Jul 03, 2025 | Jul 07, 2025 |
| Iyengar Vijay K | officer: EVP, GMAPPS | Sell | 5,935 | $68.15 | $404.47K | Jul 03, 2025 | Jul 07, 2025 |
| Denton Sheila A. | officer: EVP & General Counsel | Sell | 599 | $68.61 | $41.1K | Jul 02, 2025 | Jul 07, 2025 |
By insider
- Hoppenot Herve−$19.77Mdirector0B · 1S
- Stein Steven H−$5.72Mofficer: EVP & Chief Medical Officer0B · 6S
- Morrissey Michael James−$5.68Mofficer: EVP, Head of Tech. Operations0B · 3S
- CAGNONI PABLO J−$5.44Mofficer: President, Global Head of R&D0B · 3S
- Issa Mohamed Khairie−$1.18Mofficer: EVP, Head of US Oncology0B · 1S
- Denton Sheila A.−$935.86Kofficer: EVP & General Counsel0B · 12S
- Flannelly Barry P−$917.91Kofficer: EVP & General Manager US0B · 3S
- Iyengar Vijay K−$736.7Kofficer: EVP, GMAPPS0B · 4S
- Mayes Patrick A−$554.97Kofficer: EVP & Chief Scientific Officer0B · 2S
- Tray Thomas−$415.39Kofficer: Principal Accounting Officer0B · 4S
- Heeson Lee−$289.02Kofficer: EVP, Head of Incyte Intl0B · 1S
Beneficial ownership filings
Schedule 13D / 13G — investors holding more than 5% of INCY-US.
DB · acquisition_ownership6
| Filed | Reporting person | Form | Type | Aggregate owned | % Class | Sole voting | Shared voting | Citizenship | |
|---|---|---|---|---|---|---|---|---|---|
| Nov 08, 2024 | (1) BlackRock, Inc. | — | HC | — | +8.90% | 15.86M | 0 | Delaware | SEC → |
| Oct 21, 2024 | (1) BlackRock, Inc. | — | HC | — | +8.90% | 0 | 0 | Delaware | SEC → |
| Oct 17, 2024 | STATE STREET CORPORATION | — | HC | — | +5.50% | 0 | 7.42M | MA | SEC → |
| Mar 25, 2024 | Incyte Corporation | — | CO | — | +6.90% | 4M | 0 | Delaware | SEC → |
| Feb 14, 2022 | PAGE 2 OF 4 PAGES | — | IA | — | +7.50% | 15.97M | 0 | — | SEC → |
| Oct 12, 2021 | 52-0556948 | — | IA | — | +8.50% | 6.93M | 0 | Maryland | SEC → |
Top 10 holders · 8 quarters
13F position evolutionNo 13F history in
institutional_holders for INCY-US.